Damian Danilczuk
Research Subjects
Damian Danilczuk has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Wiktor Adamiec
City Hospital of John Paul II in Rzeszów, Rzeszów, Poland
18 shared publications - Adrianna Buż
John Paul II Municipal Hospital in Rzeszów, Rycerska 4, 35-241 Rzeszów, Poland
10 shared publications - Jerzy Buszko
Medical Care Center in Jarosław, 3-go Maja 70, 37-500 Jarosław, Poland
10 shared publications - Marta Bajkowska-Piterak
Medical Center in Łańcut, Ignacego Paderewskiego 5, 37-100 Łańcut, Poland
10 shared publications - Michał Dyś
Health Care Complex in Dębica, Krakowska 91, 39-200 Dębica, Poland
10 shared publications - Monika Szlachta-Gubernat
Hospital of the Ministry of Interior and Administration in Rzeszów, Krakowska 16, 35-111 Rzeszów, Poland
10 shared publications
Latest Publications
- Open Access
- 22 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(51))
ATRIAL FIBRILLATION, WEARABLE TECHNOLOGIES AND ARTIFICIAL INTELLIGENCE: CURRENT EVIDENCE, CLINICAL UTILITY AND LIMITATIONS
Background: Atrial fibrillation is the most common sustained cardiac arrhythmia in adults and represents an important clinical and public health problem because of its association with stroke, mortality, disability, and healthcare burden. Its paroxysmal and frequently asymptomatic course limits the effectiveness of conventional diagnostic strategies based on occasional electrocardiographic recordings. Aim: This narrative review aims to summarise current evidence regarding the use of wearable technologies and artificial intelligence for the detection of atrial fibrillation, with particular emphasis on diagnostic accuracy, clinical utility, and principal limitations. Methods: A structured literature search was performed using PubMed, Scopus, Web of Science, and Google Scholar. Studies published between 2021 and 2026 were primarily considered. Search terms included “atrial fibrillation,” “wearable technologies,” “smartwatch,” “electrocardiography,” “photoplethysmography,” “artificial intelligence,” “machine learning,” and “diagnostics.” Priority was given to original studies, systematic reviews, meta-analyses, and clinically relevant review articles concerning wearable devices, artificial intelligence, and atrial fibrillation detection. Earlier landmark studies were included when they were necessary to explain key evidence discussed in recent reviews and meta-analyses. Results: Wearable devices such as smartwatches, fitness bands, and portable ECG systems allow longer heart rhythm monitoring in daily life and may help detect paroxysmal and clinically silent atrial fibrillation. ECG-based devices are more consistent with current diagnostic standards, whereas photoplethysmography-based systems are more accessible and can provide passive rhythm monitoring. Artificial intelligence, especially machine learning and deep learning, can support signal interpretation, arrhythmia recognition, and risk prediction. However, diagnostic performance reported in controlled studies may not always translate directly into real-world clinical practice. Conclusions: Wearable technologies and artificial intelligence offer a promising way to support atrial fibrillation screening and monitoring. They may improve early detection, especially in asymptomatic individuals, but should not replace standard diagnostic methods. Photoplethysmography-based alerts should be regarded as screening signals, while a final diagnosis of atrial fibrillation should still be confirmed by ECG in an appropriate clinical context. More large-scale studies are needed before these tools can be widely implemented in routine practice.
- 22 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(51))
Open AccessATRIAL FIBRILLATION, WEARABLE TECHNOLOGIES AND ARTIFICIAL INTELLIGENCE: CURRENT EVIDENCE, CLINICAL UTILITY AND LIMITATIONS
Background: Atrial fibrillation is the most common sustained cardiac arrhythmia in adults and represents an important clinical and public health problem because of its association with stroke, mortality, disability, and healthcare burden. Its paroxysmal and frequently asymptomatic course limits the effectiveness of conventional diagnostic strategies based on occasional electrocardiographic recordings. Aim: This narrative review aims to summarise current evidence regarding the use of wearable technologies and artificial intelligence for the detection of atrial fibrillation, with particular emphasis on diagnostic accuracy, clinical utility, and principal limitations. Methods: A structured literature search was performed using PubMed, Scopus, Web of Science, and Google Scholar. Studies published between 2021 and 2026 were primarily considered. Search terms included “atrial fibrillation,” “wearable technologies,” “smartwatch,” “electrocardiography,” “photoplethysmography,” “artificial intelligence,” “machine learning,” and “diagnostics.” Priority was given to original studies, systematic reviews, meta-analyses, and clinically relevant review articles concerning wearable devices, artificial intelligence, and atrial fibrillation detection. Earlier landmark studies were included when they were necessary to explain key evidence discussed in recent reviews and meta-analyses. Results: Wearable devices such as smartwatches, fitness bands, and portable ECG systems allow longer heart rhythm monitoring in daily life and may help detect paroxysmal and clinically silent atrial fibrillation. ECG-based devices are more consistent with current diagnostic standards, whereas photoplethysmography-based systems are more accessible and can provide passive rhythm monitoring. Artificial intelligence, especially machine learning and deep learning, can support signal interpretation, arrhythmia recognition, and risk prediction. However, diagnostic performance reported in controlled studies may not always translate directly into real-world clinical practice. Conclusions: Wearable technologies and artificial intelligence offer a promising way to support atrial fibrillation screening and monitoring. They may improve early detection, especially in asymptomatic individuals, but should not replace standard diagnostic methods. Photoplethysmography-based alerts should be regarded as screening signals, while a final diagnosis of atrial fibrillation should still be confirmed by ECG in an appropriate clinical context. More large-scale studies are needed before these tools can be widely implemented in routine practice.
- Open Access
- 22 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(51))
THE BIDIRECTIONAL RELATIONSHIP BETWEEN INSOMNIA AND DEPRESSION IN THE DIGITAL AGE: A STRUCTURED NARRATIVE REVIEW
Introduction: Insomnia and depression are common psychiatric conditions that significantly impact global health. Recent evidence shows a bidirectional relationship between these disorders, influenced by lifestyle changes and widespread digital technology use. Objective: This structured narrative review analyzes the two -way relationship between insomnia and depression in the digital period, focusing on neurobiological, behavioral, and technology -related mechanisms. Materials and Methods: We conducted a structured narrative review across PubMed, Scopus, and Web of Science. The review covered peer -reviewed longitudinal studies, systematic reviews, and meta -analyses published over the last 10 to 15 years that focused on digital behaviors such as screen time and social media use. Because the studies used different methods and reported different results, we used a qualitative synthesis. Results: According to the studies, depression and sleeplessness are tightly related. Depression frequently results in persistent sleep issues, such as poor quality sleep, difficulty falling asleep, and altered sleep patterns, and insomnia can increase the risk of depression. Similar elements, including abnormalities with the HPA axis, circadian rhythms, and neurotransmitters, link the two diseases. Sleep issues and an increased risk of depression are also linked to excessive use of internet -based platforms such as Instagram and TikTok. Conclusions: Insomnia and depression are closely connected and can make each other worse through both biological and behavioral factors. Today, technology also has a big impact on this relationship. Spotting and treating sleep problems early, along with using technology responsibly, may help reduce the risk and severity of depression. Adding sleep -focused and technology -aware strategies to mental health care can lead to better results and help prevent problems.
- 22 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(51))
Open AccessTHE BIDIRECTIONAL RELATIONSHIP BETWEEN INSOMNIA AND DEPRESSION IN THE DIGITAL AGE: A STRUCTURED NARRATIVE REVIEW
Introduction: Insomnia and depression are common psychiatric conditions that significantly impact global health. Recent evidence shows a bidirectional relationship between these disorders, influenced by lifestyle changes and widespread digital technology use. Objective: This structured narrative review analyzes the two -way relationship between insomnia and depression in the digital period, focusing on neurobiological, behavioral, and technology -related mechanisms. Materials and Methods: We conducted a structured narrative review across PubMed, Scopus, and Web of Science. The review covered peer -reviewed longitudinal studies, systematic reviews, and meta -analyses published over the last 10 to 15 years that focused on digital behaviors such as screen time and social media use. Because the studies used different methods and reported different results, we used a qualitative synthesis. Results: According to the studies, depression and sleeplessness are tightly related. Depression frequently results in persistent sleep issues, such as poor quality sleep, difficulty falling asleep, and altered sleep patterns, and insomnia can increase the risk of depression. Similar elements, including abnormalities with the HPA axis, circadian rhythms, and neurotransmitters, link the two diseases. Sleep issues and an increased risk of depression are also linked to excessive use of internet -based platforms such as Instagram and TikTok. Conclusions: Insomnia and depression are closely connected and can make each other worse through both biological and behavioral factors. Today, technology also has a big impact on this relationship. Spotting and treating sleep problems early, along with using technology responsibly, may help reduce the risk and severity of depression. Adding sleep -focused and technology -aware strategies to mental health care can lead to better results and help prevent problems.
- Open Access
- 21 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(51))
DEEP LEARNING–ASSISTED FRACTURE DETECTION ON PLAIN RADIOGRAPHS: DIAGNOSTIC ACCURACY, CLINICAL INTEGRATION, AND FUTURE DIRECTIONS
Introduction and Purpose. Fractures are a major global health burden, and a non-trivial fraction of fractures presenting to emergency and urgent care settings are initially missed on plain radiographs, causing diagnostic delay and avoidable morbidity. This review appraises the current state of deep learning for fracture detection on conventional radiography, addressing standalone accuracy, the effect of algorithmic assistance on readers, and the conditions of clinical integration. Brief Description of the State of Knowledge. Across recent meta-analyses, pooled sensitivity and specificity for fracture detection on radiographs cluster in the low-to-mid nineties, with summary AUROC approaching 0.97 in the largest synthesis. The literature is unevenly distributed across the skeleton: the wrist and the hip dominate the evidence base, the pediatric elbow is moderately developed, and other regions remain represented by only a handful of studies. Algorithmic assistance lifts reader sensitivity by several percentage points without a specificity penalty, with the largest gains in clinicians who have less musculoskeletal imaging experience. Summary. Deep learning is mature for narrow fracture-detection tasks in the appendicular skeleton, but not yet for broad deployment claims. External validation across institutions and vendors, prospective evaluation tied to clinical endpoints, and standards-based integration into PACS and reporting infrastructure are the conditions that would move these tools from accuracy benchmarks toward measurable patient benefit. The clearest near-term value lies in decision support that narrows the diagnostic gap for less experienced readers.
- 21 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(51))
Open AccessDEEP LEARNING–ASSISTED FRACTURE DETECTION ON PLAIN RADIOGRAPHS: DIAGNOSTIC ACCURACY, CLINICAL INTEGRATION, AND FUTURE DIRECTIONS
Introduction and Purpose. Fractures are a major global health burden, and a non-trivial fraction of fractures presenting to emergency and urgent care settings are initially missed on plain radiographs, causing diagnostic delay and avoidable morbidity. This review appraises the current state of deep learning for fracture detection on conventional radiography, addressing standalone accuracy, the effect of algorithmic assistance on readers, and the conditions of clinical integration. Brief Description of the State of Knowledge. Across recent meta-analyses, pooled sensitivity and specificity for fracture detection on radiographs cluster in the low-to-mid nineties, with summary AUROC approaching 0.97 in the largest synthesis. The literature is unevenly distributed across the skeleton: the wrist and the hip dominate the evidence base, the pediatric elbow is moderately developed, and other regions remain represented by only a handful of studies. Algorithmic assistance lifts reader sensitivity by several percentage points without a specificity penalty, with the largest gains in clinicians who have less musculoskeletal imaging experience. Summary. Deep learning is mature for narrow fracture-detection tasks in the appendicular skeleton, but not yet for broad deployment claims. External validation across institutions and vendors, prospective evaluation tied to clinical endpoints, and standards-based integration into PACS and reporting infrastructure are the conditions that would move these tools from accuracy benchmarks toward measurable patient benefit. The clearest near-term value lies in decision support that narrows the diagnostic gap for less experienced readers.
- Open Access
- 7 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
AI-DRIVEN OCULOMICS: RETINAL IMAGING BIOMARKERS FOR SYSTEMIC DISEASE - FROM CARDIOVASCULAR RISK TO NEURODEGENERATION AND FOUNDATION MODELS
Introduction and aim: The retina offers a unique, non-invasive window into systemic vascular and neurological health. Deep-learning algorithms applied to retinal photographs and optical coherence tomography (OCT) can predict cardiovascular events, detect chronic kidney disease, estimate biological age, and identify neurodegenerative diseases - a field termed oculomics. This review synthesizes current evidence on AI-driven oculomics across cardiovascular, cardio-renal-metabolic, neurodegenerative, and aging domains. Materials and methods: A narrative review was conducted in PubMed, Scopus, and Google Scholar for studies published 2018-2026. Original research, validation studies, and major reviews on AI-based prediction of systemic disease from retinal imaging were included. Results: Deep-learning models trained on fundus photographs predict major adverse cardiovascular events and ten-year atherosclerotic cardiovascular disease risk with areas under the receiver operating characteristic curve (AUROCs) of 0.70-0.89. Chronic kidney disease detection achieves AUROCs of 0.85-0.94. Alzheimer’s disease classifiers reach AUROCs of 0.93 in development cohorts and 0.73-0.91 in external validation, while Parkinson’s disease detection achieves AUROCs of 0.77-0.92. Retinal age-gap independently predicts mortality. Self-supervised foundation models (RETFound, VisionFM, EyeFound, RETFound-Green, MIRAGE, V-JEPA) show state-of-the-art performance, with volumetric OCT (V-JEPA) reaching AUROCs of 0.94. Conclusions: AI-driven oculomics is a rapidly maturing field with strong translational potential. Despite encouraging accuracies, prospective validation, algorithmic bias, regulatory approval, and clinical integration remain key challenges. Future work should prioritize multi-ethnic cohort studies, cost-effectiveness analyses, and regulatory pathways.
- 7 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
Open AccessAI-DRIVEN OCULOMICS: RETINAL IMAGING BIOMARKERS FOR SYSTEMIC DISEASE - FROM CARDIOVASCULAR RISK TO NEURODEGENERATION AND FOUNDATION MODELS
Introduction and aim: The retina offers a unique, non-invasive window into systemic vascular and neurological health. Deep-learning algorithms applied to retinal photographs and optical coherence tomography (OCT) can predict cardiovascular events, detect chronic kidney disease, estimate biological age, and identify neurodegenerative diseases - a field termed oculomics. This review synthesizes current evidence on AI-driven oculomics across cardiovascular, cardio-renal-metabolic, neurodegenerative, and aging domains. Materials and methods: A narrative review was conducted in PubMed, Scopus, and Google Scholar for studies published 2018-2026. Original research, validation studies, and major reviews on AI-based prediction of systemic disease from retinal imaging were included. Results: Deep-learning models trained on fundus photographs predict major adverse cardiovascular events and ten-year atherosclerotic cardiovascular disease risk with areas under the receiver operating characteristic curve (AUROCs) of 0.70-0.89. Chronic kidney disease detection achieves AUROCs of 0.85-0.94. Alzheimer’s disease classifiers reach AUROCs of 0.93 in development cohorts and 0.73-0.91 in external validation, while Parkinson’s disease detection achieves AUROCs of 0.77-0.92. Retinal age-gap independently predicts mortality. Self-supervised foundation models (RETFound, VisionFM, EyeFound, RETFound-Green, MIRAGE, V-JEPA) show state-of-the-art performance, with volumetric OCT (V-JEPA) reaching AUROCs of 0.94. Conclusions: AI-driven oculomics is a rapidly maturing field with strong translational potential. Despite encouraging accuracies, prospective validation, algorithmic bias, regulatory approval, and clinical integration remain key challenges. Future work should prioritize multi-ethnic cohort studies, cost-effectiveness analyses, and regulatory pathways.
- Open Access
- 7 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
AMYOTROPHIC LATERAL SCLEROSIS: RISK FACTORS, DIAGNOSTIC DELAYS, MODERN DIAGNOSTIC METHODS, AND FUTURE POSSIBILITIES- LITERATURE REVIEW
Introduction and purpose. Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease affecting motor neurons. It affects about 4-5 persons per 100000 population and is characterized by varied clinical presentation and short survival period. ALS remains incurable; however, patients can receive multidisciplinary care and disease-modifying drugs. This article focuses on ALS protective and risk factors, diagnostic delays, modern diagnostic methods, and a future prospects for enhancing the diagnostic process. Material and methods. The review is based on research of articles published between 2020 and 2026 in databases such as Google Schoolar and PubMed. English-language publications were selected by the authors. Results and Conclusions. Head trauma, military service, chemicals, heavy metals, electrical injuries, magnetic field exposure, history of stroke, and hypertension are associated with higher risk of ALS. Diabetes mellitus, antidiabetic and antihypertensive drugs, higher premorbid BMI, live in urban, and kidney diseases may be protective factors. Diagnostic criteria and EMG are crucial tools in diagnostics. Gold Coast criteria are characterized by increased diagnostic sensitivity compared to previous criteria. Diagnostics remains a challenge, and definitive diagnosis is established with a significant delay due to patient- and healthcare system-dependent factors. ALS remains incurable. Nevertheless, eliminating diagnostic difficulties may provide a number of benefits for both patients and the healthcare system. Scientists attempt to facilitate the diagnostic process. Numerous publications highlight the potential of modern technologies. The results seem promising, however, these techniques have a number of limitations and involve a risk, so they should be treated with caution, and require further research and improvement.
- 7 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
Open AccessAMYOTROPHIC LATERAL SCLEROSIS: RISK FACTORS, DIAGNOSTIC DELAYS, MODERN DIAGNOSTIC METHODS, AND FUTURE POSSIBILITIES- LITERATURE REVIEW
Introduction and purpose. Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease affecting motor neurons. It affects about 4-5 persons per 100000 population and is characterized by varied clinical presentation and short survival period. ALS remains incurable; however, patients can receive multidisciplinary care and disease-modifying drugs. This article focuses on ALS protective and risk factors, diagnostic delays, modern diagnostic methods, and a future prospects for enhancing the diagnostic process. Material and methods. The review is based on research of articles published between 2020 and 2026 in databases such as Google Schoolar and PubMed. English-language publications were selected by the authors. Results and Conclusions. Head trauma, military service, chemicals, heavy metals, electrical injuries, magnetic field exposure, history of stroke, and hypertension are associated with higher risk of ALS. Diabetes mellitus, antidiabetic and antihypertensive drugs, higher premorbid BMI, live in urban, and kidney diseases may be protective factors. Diagnostic criteria and EMG are crucial tools in diagnostics. Gold Coast criteria are characterized by increased diagnostic sensitivity compared to previous criteria. Diagnostics remains a challenge, and definitive diagnosis is established with a significant delay due to patient- and healthcare system-dependent factors. ALS remains incurable. Nevertheless, eliminating diagnostic difficulties may provide a number of benefits for both patients and the healthcare system. Scientists attempt to facilitate the diagnostic process. Numerous publications highlight the potential of modern technologies. The results seem promising, however, these techniques have a number of limitations and involve a risk, so they should be treated with caution, and require further research and improvement.
- Open Access
- 7 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
SMARTPHONE-BASED AND INFRARED THERMOGRAPHY FOR HOME PREVENTION OF DIABETIC FOOT ULCERS: ACCESSIBILITY, ADOPTION, AND HEALTH-EQUITY PERSPECTIVE
Home infrared temperature monitoring for diabetic foot ulcer (DFU) prevention is supported by multiple randomized controlled trials demonstrating reductions of roughly 60 to 90% in ulcer recurrence among high-risk patients (IWGDF risk categories 2 to 3) when compared with standard care without thermometry. These findings hold across diverse geographic and resource settings, including low-resource contexts in Indonesia and Peru. Technology platforms range from handheld infrared thermometers costing 30 to 100 US dollars to smartphone-attached thermal cameras, wireless thermometric mats, sensor-embedded socks rated 9 to 10 out of 10 for comfort, and wearable Internet-of-Things devices costing as little as 14.80 US dollars per unit. Adherence rates across technologies generally range from 70% to 88% over study periods of 6 to 24 months, and predictive systems can detect impending ulcers up to 37 days in advance with 97% sensitivity, though at the cost of a 57% false-positive rate at standard thresholds. Despite promising accessibility features, significant barriers remain, including physical limitations such as arthritis and vision loss, incorrect device use in nearly half of participants despite training, and reliance on assistance from others for interpreting results among older, low-income users, all of which disproportionately affect vulnerable populations. Critically, no study formally evaluated differential effectiveness by socioeconomic status, race or ethnicity, education level, or insurance coverage, leaving a substantial gap in the health-equity evidence base. The addition of mHealth reminders to thermometry did not improve adherence or outcomes beyond thermometry alone. While the technological and cost barriers to home thermometry are increasingly surmountable, the absence of equity-stratified analyses means that whether these tools reduce or inadvertently widen disparities in DFU outcomes cannot yet be determined from the available evidence.
- 7 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
Open AccessSMARTPHONE-BASED AND INFRARED THERMOGRAPHY FOR HOME PREVENTION OF DIABETIC FOOT ULCERS: ACCESSIBILITY, ADOPTION, AND HEALTH-EQUITY PERSPECTIVE
Home infrared temperature monitoring for diabetic foot ulcer (DFU) prevention is supported by multiple randomized controlled trials demonstrating reductions of roughly 60 to 90% in ulcer recurrence among high-risk patients (IWGDF risk categories 2 to 3) when compared with standard care without thermometry. These findings hold across diverse geographic and resource settings, including low-resource contexts in Indonesia and Peru. Technology platforms range from handheld infrared thermometers costing 30 to 100 US dollars to smartphone-attached thermal cameras, wireless thermometric mats, sensor-embedded socks rated 9 to 10 out of 10 for comfort, and wearable Internet-of-Things devices costing as little as 14.80 US dollars per unit. Adherence rates across technologies generally range from 70% to 88% over study periods of 6 to 24 months, and predictive systems can detect impending ulcers up to 37 days in advance with 97% sensitivity, though at the cost of a 57% false-positive rate at standard thresholds. Despite promising accessibility features, significant barriers remain, including physical limitations such as arthritis and vision loss, incorrect device use in nearly half of participants despite training, and reliance on assistance from others for interpreting results among older, low-income users, all of which disproportionately affect vulnerable populations. Critically, no study formally evaluated differential effectiveness by socioeconomic status, race or ethnicity, education level, or insurance coverage, leaving a substantial gap in the health-equity evidence base. The addition of mHealth reminders to thermometry did not improve adherence or outcomes beyond thermometry alone. While the technological and cost barriers to home thermometry are increasingly surmountable, the absence of equity-stratified analyses means that whether these tools reduce or inadvertently widen disparities in DFU outcomes cannot yet be determined from the available evidence.
- Open Access
- 4 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
HANDHELD AND POCKET-SIZED ULTRASOUND FOR ABDOMINAL AORTIC ANEURYSM SCREENING BEYOND THE RADIOLOGY SUITE: ACCESS, TASK-SHIFTING, AND REGULATORY CONSIDERATIONS
Handheld and pocket-sized ultrasound devices enable accurate abdominal aortic aneurysm (AAA) screening across a wide range of non-radiology settings and operator types. This review synthesizes evidence from 26 sources spanning emergency departments, primary care offices, prehospital ambulances, and rural clinics across 12 countries. Non-radiologist operators, including family physicians, emergency physicians, paramedics, medical residents, complete novices, and nurses, achieved sensitivities of 96 to 100% and specificities of 94 to 100% for AAA detection when using focused, protocol-driven scanning. Training requirements ranged from 15 minutes for deep learning-guided nurses to 15 to 25 hours for unassisted clinicians, with measurement accuracy generally within 0.2 to 0.5 cm of reference standards. AI-guided systems reduced training to minutes while maintaining physician-comparable accuracy (100% sensitivity, 94 to 98% specificity, mean absolute error 2.8 mm), though this evidence derives from a single research group and requires broader validation. Obesity consistently reduced diagnostic accuracy, with sensitivity improving from 86% to 96% when large body habitus patients were excluded. Screening costs of $30 to $53 per examination, with devices costing approximately 10% of standard ultrasound machines, support economic viability; cost-utility modeling found opportunistic primary care scanning to be cost-saving for medium and large aneurysms. The principal barriers to broader implementation are not diagnostic accuracy but structural: the absence of standardized credentialing and training requirements across jurisdictions, unresolved coding and reimbursement pathways for non-radiologist point-of-care ultrasound (POCUS) screening, low screening uptake even with decision support, and additional regulatory complexity for AI-guided devices. Successful programs combined institutional endorsement, focused scanning protocols, short dedicated training, workflow adaptations such as nurse-directed ordering, and clear referral pathways for positive cases. Countries with centralized screening programs appear better positioned to integrate POCUS-based AAA screening than fragmented systems requiring individual practitioner navigation of reimbursement.
- 4 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
Open AccessHANDHELD AND POCKET-SIZED ULTRASOUND FOR ABDOMINAL AORTIC ANEURYSM SCREENING BEYOND THE RADIOLOGY SUITE: ACCESS, TASK-SHIFTING, AND REGULATORY CONSIDERATIONS
Handheld and pocket-sized ultrasound devices enable accurate abdominal aortic aneurysm (AAA) screening across a wide range of non-radiology settings and operator types. This review synthesizes evidence from 26 sources spanning emergency departments, primary care offices, prehospital ambulances, and rural clinics across 12 countries. Non-radiologist operators, including family physicians, emergency physicians, paramedics, medical residents, complete novices, and nurses, achieved sensitivities of 96 to 100% and specificities of 94 to 100% for AAA detection when using focused, protocol-driven scanning. Training requirements ranged from 15 minutes for deep learning-guided nurses to 15 to 25 hours for unassisted clinicians, with measurement accuracy generally within 0.2 to 0.5 cm of reference standards. AI-guided systems reduced training to minutes while maintaining physician-comparable accuracy (100% sensitivity, 94 to 98% specificity, mean absolute error 2.8 mm), though this evidence derives from a single research group and requires broader validation. Obesity consistently reduced diagnostic accuracy, with sensitivity improving from 86% to 96% when large body habitus patients were excluded. Screening costs of $30 to $53 per examination, with devices costing approximately 10% of standard ultrasound machines, support economic viability; cost-utility modeling found opportunistic primary care scanning to be cost-saving for medium and large aneurysms. The principal barriers to broader implementation are not diagnostic accuracy but structural: the absence of standardized credentialing and training requirements across jurisdictions, unresolved coding and reimbursement pathways for non-radiologist point-of-care ultrasound (POCUS) screening, low screening uptake even with decision support, and additional regulatory complexity for AI-guided devices. Successful programs combined institutional endorsement, focused scanning protocols, short dedicated training, workflow adaptations such as nurse-directed ordering, and clear referral pathways for positive cases. Countries with centralized screening programs appear better positioned to integrate POCUS-based AAA screening than fragmented systems requiring individual practitioner navigation of reimbursement.
- Open Access
- 27 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
CONTACTLESS AND CONTACT-BASED SMARTPHONE PHOTOPLETHYSMOGRAPHY AS A MULTI-PARAMETER CARDIOMETABOLIC HOME SCREEN: BEYOND ATRIAL FIBRILLATION TOWARD BLOOD PRESSURE AND DYSGLYCEMIA ESTIMATION
Smartphone photoplethysmography (PPG) demonstrates a stark maturity gradient across cardiometabolic parameters. For atrial fibrillation (AF) detection, meta-analytic evidence from 14 studies (n = 5,090) shows pooled sensitivity of 96% (95% CI 93 to 97%) and specificity of 97% (95% CI 95 to 98%), with individual validation studies reporting sensitivity up to 99.7% and specificity up to 99.7% using machine learning algorithms in ambulatory settings. AF detection performance is consistent across multiple smartphone devices, robust in unsupervised home use, and clinically impactful: population screening increased oral anticoagulation uptake from 56% to 74%, and digital post-ablation monitoring detected arrhythmia recurrence at more than double the rate of conventional ECG follow-up (38.5% versus 17.7%, OR 3.4). Signal quality rates for PPG (89 to 97%) were comparable to or exceeded those for single-lead ECG. Blood pressure (BP) estimation, by contrast, remains unreliable for population-level screening. Of 18 studies evaluated, only two clearly passed established AAMI/ESH/ISO validation protocols, both relying on per-individual calibration against a reference measurement. The two largest prospective trials (n = 965 and n = 62) explicitly failed validation standards, and contactless remote PPG showed critically low sensitivity for hypertension detection (systolic BP sensitivity 0.04) in a diverse-skinned field population. Diastolic BP was consistently estimated more accurately than systolic BP across approaches. Dysglycemia detection rests on a single large study demonstrating moderate screening discrimination (AUC 0.74 to 0.77) using a deep neural network applied to PPG waveforms, with the score independently associated with HbA1c. The evidence supports smartphone PPG as a clinically ready tool for AF detection and monitoring, particularly in populations aged over 65, but BP estimation requires individual calibration and cannot yet substitute for cuff-based measurement, and dysglycemia screening remains investigational.
- 27 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
Open AccessCONTACTLESS AND CONTACT-BASED SMARTPHONE PHOTOPLETHYSMOGRAPHY AS A MULTI-PARAMETER CARDIOMETABOLIC HOME SCREEN: BEYOND ATRIAL FIBRILLATION TOWARD BLOOD PRESSURE AND DYSGLYCEMIA ESTIMATION
Smartphone photoplethysmography (PPG) demonstrates a stark maturity gradient across cardiometabolic parameters. For atrial fibrillation (AF) detection, meta-analytic evidence from 14 studies (n = 5,090) shows pooled sensitivity of 96% (95% CI 93 to 97%) and specificity of 97% (95% CI 95 to 98%), with individual validation studies reporting sensitivity up to 99.7% and specificity up to 99.7% using machine learning algorithms in ambulatory settings. AF detection performance is consistent across multiple smartphone devices, robust in unsupervised home use, and clinically impactful: population screening increased oral anticoagulation uptake from 56% to 74%, and digital post-ablation monitoring detected arrhythmia recurrence at more than double the rate of conventional ECG follow-up (38.5% versus 17.7%, OR 3.4). Signal quality rates for PPG (89 to 97%) were comparable to or exceeded those for single-lead ECG. Blood pressure (BP) estimation, by contrast, remains unreliable for population-level screening. Of 18 studies evaluated, only two clearly passed established AAMI/ESH/ISO validation protocols, both relying on per-individual calibration against a reference measurement. The two largest prospective trials (n = 965 and n = 62) explicitly failed validation standards, and contactless remote PPG showed critically low sensitivity for hypertension detection (systolic BP sensitivity 0.04) in a diverse-skinned field population. Diastolic BP was consistently estimated more accurately than systolic BP across approaches. Dysglycemia detection rests on a single large study demonstrating moderate screening discrimination (AUC 0.74 to 0.77) using a deep neural network applied to PPG waveforms, with the score independently associated with HbA1c. The evidence supports smartphone PPG as a clinically ready tool for AF detection and monitoring, particularly in populations aged over 65, but BP estimation requires individual calibration and cannot yet substitute for cuff-based measurement, and dysglycemia screening remains investigational.
- Open Access
- 26 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
FIRST-GENERATION BRAIN–COMPUTER INTERFACES: A NARRATIVE REVIEW OF CLINICAL TRANSLATION, COMPARATIVE SAFETY, AND NEURO-RIGHTS
Objectives. This narrative review examines first-generation brain-computer interfaces (BCIs) across three domains: clinical translation in amyotrophic lateral sclerosis (ALS), locked-in syn-drome (LIS), tetraplegia, spinal cord injury (SCI), pharmacoresistant epilepsy and movement dis-orders; comparative safety covering neurological, infectious, technical and cybersecurity risks; and the emerging neuro-rights regulatory debate. Methods. Literature was retrieved from PubMed/MEDLINE, Scopus, Web of Science, IEEE Xplore and legal-academic databases, covering peer-reviewed clinical trials, systematic reviews, safety datasets, technical analyses and bioethics scholarship through 2026. Key Findings. The BrainGate dataset (14 adults, 12,203 implant-days) reported 68 device-related adverse events and six serious adverse events, with no intracranial infections, explantations or at-tributable deaths. The endovascular SWITCH trial found zero serious adverse events at 12 months. Safety risk follows access route and implant chronicity rather than a simple invasive/non-invasive binary. Closed-loop neurostimulation reduces seizure frequency by 60-65% in pharmacoresistant epilepsy; adaptive deep brain stimulation is the most mature movement-disorder application. The neuro-rights literature converges on mental privacy, integrity, autonomy and cognitive liberty as core protected interests. Conclusions. Responsible BCI deployment requires matching the least invasive platform to the indication, consent specific to device capabilities, cybersecurity treated as patient safety, and pro-spective neural-data governance built into device design.
- 26 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
Open AccessFIRST-GENERATION BRAIN–COMPUTER INTERFACES: A NARRATIVE REVIEW OF CLINICAL TRANSLATION, COMPARATIVE SAFETY, AND NEURO-RIGHTS
Objectives. This narrative review examines first-generation brain-computer interfaces (BCIs) across three domains: clinical translation in amyotrophic lateral sclerosis (ALS), locked-in syn-drome (LIS), tetraplegia, spinal cord injury (SCI), pharmacoresistant epilepsy and movement dis-orders; comparative safety covering neurological, infectious, technical and cybersecurity risks; and the emerging neuro-rights regulatory debate. Methods. Literature was retrieved from PubMed/MEDLINE, Scopus, Web of Science, IEEE Xplore and legal-academic databases, covering peer-reviewed clinical trials, systematic reviews, safety datasets, technical analyses and bioethics scholarship through 2026. Key Findings. The BrainGate dataset (14 adults, 12,203 implant-days) reported 68 device-related adverse events and six serious adverse events, with no intracranial infections, explantations or at-tributable deaths. The endovascular SWITCH trial found zero serious adverse events at 12 months. Safety risk follows access route and implant chronicity rather than a simple invasive/non-invasive binary. Closed-loop neurostimulation reduces seizure frequency by 60-65% in pharmacoresistant epilepsy; adaptive deep brain stimulation is the most mature movement-disorder application. The neuro-rights literature converges on mental privacy, integrity, autonomy and cognitive liberty as core protected interests. Conclusions. Responsible BCI deployment requires matching the least invasive platform to the indication, consent specific to device capabilities, cybersecurity treated as patient safety, and pro-spective neural-data governance built into device design.
- Open Access
- 25 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
ADVANCES AND CHALLENGES IN CONTINUOUS GLUCOSE MONITORING FOR DIABETES MANAGEMENT. A NARRATIVE REVIEW
Diabetes mellitus is a major challenge for global health. It is characterized by rising prevalence, often delayed diagnosis, and significant clinical and economic burden. During the last two decades, Continuous Glucose Monitoring systems have become one of the most important developments in the management of DM. In this short review, we will describe the importance of the research on CGM systems, their advantages over previously available monitoring methods, as well as their limitations that still need to be addressed by manufacturers and physicians managing patients' treatment. We also dedicate a section of this article to newly emerging solutions, including insulin therapy with CGMs as a base and new directions in CGM applications across the medical field.
- 25 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
Open AccessADVANCES AND CHALLENGES IN CONTINUOUS GLUCOSE MONITORING FOR DIABETES MANAGEMENT. A NARRATIVE REVIEW
Diabetes mellitus is a major challenge for global health. It is characterized by rising prevalence, often delayed diagnosis, and significant clinical and economic burden. During the last two decades, Continuous Glucose Monitoring systems have become one of the most important developments in the management of DM. In this short review, we will describe the importance of the research on CGM systems, their advantages over previously available monitoring methods, as well as their limitations that still need to be addressed by manufacturers and physicians managing patients' treatment. We also dedicate a section of this article to newly emerging solutions, including insulin therapy with CGMs as a base and new directions in CGM applications across the medical field.